Skip to main content
Clinical Trials/NCT05517824
NCT05517824CompletedNot Applicable

Efficacy and Safety of the Micro-insulated Needle Radiofrequency Device for Reduction of Submental Fat

Seoul National University Bundang Hospital1 site in 1 country24 target enrollmentStarted: June 7, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
24
Locations
1
Primary Endpoint
Physician-Assisted Submental Fat Rating Scale score from 0 (nothing) to 4 (very severe)

Study Overview

Brief Summary

The investigators aimed to evaluate the efficacy and safety of a fractional radiofrequency device with a micro-insulated needle to reduce submental fat.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Sequential
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients with excess submental fat on a grade of 1~4, as assessed by the Physician-Assisted Submental Fat Rating Scale

Exclusion Criteria

  • mental impairment, infectious disease
  • history of keloid development
  • pregnancy, pacemaker
  • use of anticoagulants
  • undergoing a facelift procedure within the prior 6 months.

Arms & Interventions

Post-treatment

Active Comparator

After a single treatment using a microinsulated needle RF device

Intervention: microinsulated needle radiofrequency (Procedure)

Pre-treatment (Baseline)

No Intervention

Outcomes

Primary Outcomes

Physician-Assisted Submental Fat Rating Scale score from 0 (nothing) to 4 (very severe)

Time Frame: 1 month after the treatment

submental fat rating by an independent investigator

Secondary Outcomes

  • submental fat volume (cc)(1 month after the treatment)
  • patient satisfaction score from 0 (not satisfied) to 10 (most satisfied)(1 month after the treatment)
  • any adverse effects at any time during or after treatment(assessed through study completion, an average of 2 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jung-Won Shin

Associate Professor

Seoul National University Bundang Hospital

Study Sites (1)

Loading locations...

Similar Trials